1. E19: a selective approach to safety data collection in specific late-stage preapproval or post-approval clinical trials : guidance for industry Publication: Silver Spring, MD : Center for Drug Evaluation and Research, December 2022 Subject(s): Clinical Trials as TopicData CollectionGovernment RegulationPatient SafetyUnited StatesUnited States. Food and Drug Administration
2. Safety considerations for container labels and carton labeling design to minimize medication errors Publication: Silver Spring, MD : Center for Drug Evaluation and Research, May 2022 Subject(s): Drug Labeling -- legislation & jurisprudenceMedication Errors -- prevention & controlPatient SafetyUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
3. Adverse events in hospitals. A quarter of Medicare patients experienced harm in October 2018 Publication: Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2022 Subject(s): Government RegulationHospitalsMedicarePatient Harm -- prevention & controlPatient Harm -- statistics & numerical dataPatient SafetyUnited States